539206 — Genomic Valley Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹189.38m
- IN₹185.20m
- IN₹1.65m
Annual cashflow statement for Genomic Valley Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.06 | -5.02 | -4.21 | 9.13 | 0.151 |
| Depreciation | |||||
| Non-Cash Items | -0.022 | 0 | -3.41 | -0.425 | -0.015 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.553 | 18 | -14.5 | -16.6 | -0.348 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4.37 | 14.8 | -21.3 | -7.79 | -0.201 |
| Capital Expenditures | -4.77 | -15.8 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.022 | -0 | 36.7 | 15.2 | -0.152 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.75 | -15.8 | 36.7 | 15.2 | -0.152 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 0.683 | -15.5 | -7.04 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.373 | -0.263 | -0.088 | 0.386 | -0.352 |